trans-sodium-crocetinate and Cognition-Disorders

trans-sodium-crocetinate has been researched along with Cognition-Disorders* in 2 studies

Other Studies

2 other study(ies) available for trans-sodium-crocetinate and Cognition-Disorders

ArticleYear
Trans-crocetin improves amyloid-β degradation in monocytes from Alzheimer's Disease patients.
    Journal of the neurological sciences, 2017, Jan-15, Volume: 372

    Herbal medicines have been recently employed in research and clinical studies for the potential treatment of behavioral and psychological symptoms associated with Alzheimer's Disease (AD) and other types of dementia. The present study investigates the effect of trans-crocetin, an active constituent of Crocus sativus L., to restore in vitro the reduced ability of AD patients' monocytes to degrade amyloid-β

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Analysis of Variance; Antioxidants; Carotenoids; Cathepsin B; Cognition Disorders; Crocus; Dose-Response Relationship, Drug; Female; Humans; Lipopolysaccharide Receptors; Male; Monocytes; Peptide Fragments; Proteolysis; Vitamin A

2017
Neuroprotective efficacy of Nardostachys jatamansi and crocetin in conjunction with selenium in cognitive impairment.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2012, Volume: 33, Issue:5

    Oxidative stress leads to complex biochemical alterations, and has been implicated in the progressive loss of learning and memory. Supplementing and boosting the endogenous antioxidant defense system could impede the progression of various types of neurodegeneration. In the present study, we have investigated the neuroprotective efficacy of a low-dose combination of certain promising and powerful natural antioxidants in an experimental model of cognitive impairment. Combined pretreatment with the extract of Nardosatchys jatamansi (N), crocetin (C) and selenium (Se) as sodium selenite (N, 200 mg/kg + C, 25 μg/kg + Se, 0.05 mg/kg body weight) for 15 days led to improved behavioral outcomes in streptozotocin (STZ)-induced cognitive impairment in rats. While intracerebroventricular (ICV) infusion of STZ resulted in the significant elevation of markers of oxidative stress and depletion of endogenous antioxidant defense system in the vehicle-pretreated group, these markers of oxidative stress and antioxidant enzymatic as well as non-enzymatic defense lines were attenuated in the group pretreated with the combination of antioxidants (NCSe). NCSe pretreatment markedly improved the performance of animals in passive avoidance test and Morris water maze (MWM) tasks, significantly reduced the level of TBARS, and elevated the content of glutathione and activities of antioxidant enzymes (glutathione peroxidase, glutathione-S-transferase and catalase). Our study reflects the synergistic potential of the above combination and concludes that a multimodal approach could be beneficial rather than a singular intervention.

    Topics: Animals; Antioxidants; Carotenoids; Cognition Disorders; Male; Maze Learning; Memory; Nardostachys; Oxidative Stress; Phytotherapy; Rats; Rats, Wistar; Selenium; Vitamin A

2012